Marc A M J van Zandvoort
Overview
Explore the profile of Marc A M J van Zandvoort including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
2139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rademakers T, Manca M, Jin H, Orban T, Perisic L, Frissen H, et al.
Angiogenesis
. 2024 May;
27(3):461-474.
PMID: 38780883
The presence of atherosclerotic plaque vessels is a critical factor in plaque destabilization. This may be attributable to the leaky phenotype of these microvessels, although direct proof for this notion...
2.
Ahmadian S, Lindsey P, Smeets H, van Tienen F, van Zandvoort M
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732037
Mitochondria are the energy factories of a cell, and depending on the metabolic requirements, the mitochondrial morphology, quantity, and membrane potential in a cell change. These changes are frequently assessed...
3.
You W, Knoops K, Boesten I, Berendschot T, van Zandvoort M, Benedikter B, et al.
Cell Commun Signal
. 2024 Jan;
22(1):88.
PMID: 38297331
Background: Retinal ganglion cell (RGC) degeneration and death cause vision loss in patients with glaucoma. Regulated cell death, once initiated, is generally considered to be an irreversible process. Recently, we...
4.
Werner M, Kucikas V, Voss K, Abel D, Jockenhoevel S, van Zandvoort M, et al.
Tissue Eng Part C Methods
. 2023 Dec;
30(1):38-48.
PMID: 38115629
Donor cell-specific tissue-engineered (TE) implants are a promising therapy for personalized treatment of cardiovascular diseases, but current development protocols lack a stable longitudinal assessment of tissue development at subcellular resolution....
5.
You W, Zhou T, Knoops K, Berendschot T, van Zandvoort M, Germeraad W, et al.
Sci Rep
. 2023 Jul;
13(1):11045.
PMID: 37422517
Loss of neurons in chronic neurodegenerative diseases may occur over a period of many years. Once initiated, neuronal cell death is accompanied by distinct phenotypic changes including cell shrinkage, neurite...
6.
Neupane B, Pradhan K, Ortega-Ramirez A, Aidery P, Kucikas V, Marks M, et al.
J Pers Med
. 2022 Jul;
12(7).
PMID: 35887646
Background: Mutations in the () gene are responsible for about 6% of all familial dilated cardiomyopathy (DCM) cases which tend to present at a young age and follow a fulminant...
7.
Stiekema M, Houben F, Verheyen F, Borgers M, Menzel J, Meschkat M, et al.
Front Cell Dev Biol
. 2022 Jul;
10:914286.
PMID: 35784476
Invaginations of the nuclear membrane occur in different shapes, sizes, and compositions. Part of these pleiomorphic invaginations make up the nucleoplasmic reticulum (NR), while others are merely nuclear folds. We...
8.
You W, Berendschot T, Knoops K, van Zandvoort M, Webers C, Reutelingsperger C, et al.
Int J Mol Sci
. 2022 Mar;
23(5).
PMID: 35269792
Neurodegenerative diseases are generally characterized clinically by the selective loss of a distinct subset of neurons and a slow progressive course. Mounting evidence in vivo indicates that large numbers of...
9.
Kucikas V, Werner M, Schmitz-Rode T, Louradour F, van Zandvoort M
Mol Imaging Biol
. 2021 Nov;
25(1):3-17.
PMID: 34779969
In recent years, the demand for non-destructive deep-tissue imaging modalities has led to interest in multiphoton endoscopy. In contrast to bench top systems, multiphoton endoscopy enables subcellular resolution imaging in...
10.
Stiekema M, Ramaekers F, Kapsokalyvas D, van Zandvoort M, Veltrop R, Broers J
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638534
A- and B-type lamins are type V intermediate filament proteins. Mutations in the genes encoding these lamins cause rare diseases, collectively called laminopathies. A fraction of the cells obtained from...